Cary Street Partners Investment Advisory’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-238
Closed -$5.13K 1028
2023
Q3
$5.13K Hold
238
﹤0.01% 1471
2023
Q2
$5.7K Hold
238
﹤0.01% 1376
2023
Q1
$5.06K Sell
238
-4
-2% -$77 ﹤0.01% 1326
2022
Q4
$3.95K Buy
+242
New +$3.59K ﹤0.01% 1387

Other funds holding FMS

Cary Street Partners Investment Advisory's FMS Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Fresenius Medical Care (FMS) in Q4 2023, closing a stake of 238 shares — an estimated $5.13K sold.

Cary Street Partners Investment Advisory first reported a position in FMS in Q4 2022 and held it in 4 quarters. The position peaked at $5.7K in Q2 2023. 160 funds tracked by Wall St. Rank hold FMS as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Fresenius Medical Care position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 238 Fresenius Medical Care shares in Q4 2023, an estimated $5.13K.
  • Cary Street Partners Investment Advisory first reported a position in Fresenius Medical Care in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Fresenius Medical Care position peaked at $5.7K in Q2 2023.
  • 160 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.